NIKKEI 225
38,314.39 +762.23 (+2.03%) HANG SENG
16,960.47 +131.54 (+0.78%) CRUDE OIL
83.32 -0.04 (-0.05%) GOLD FUTURES
2,331.70 -10.40 (-0.44%) DOW
38,503.69 +263.71 (+0.69%) Bitcoin GBP
53,536.71 -167.68 (-0.31%)
Valneva SE (INRLF)
| Previous close | 4.0040 |
| Open | 3.9000 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 3.9000 - 3.9000 |
| 52-week range | 3.3500 - 8.5500 |
| Volume | |
| Avg. volume | 1,020 |
| Market cap | 550.204M |
| Beta (5Y monthly) | 0.83 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
Declaration of voting rights - Valneva SE, March 2024
VALNEVA Declaration of shares and voting rights March 31, 2024__________________________________________________________________________________________ Company name: VALNEVARegistered office: 6 rue Alain Bombard, 44800 Saint-Herblain (France)Regulated market of Euronext Paris - Compartment B Declaration date: April 4, 2024 Number of shares composing the share capital of ValnevaTotal number of voting rights including suspended voting rights*Description of the change Date on which this change was
- GlobeNewswire
Valneva Initiates Phase 1 Trial of Second-Generation Zika Vaccine Candidate
Saint-Herblain (France), March 26, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced the initiation of a Phase 1 clinical trial to investigate the the safety and immunogenicity of VLA1601, its second-generation adjuvanted inactivated vaccine candidate against the Zika virus (ZIKV). There are currently no preventive vaccines or effective treatments available against ZIKV. As such, this mosquito-borne disease remains a public health threat and is i
- Globe Newswire
Valneva Announces Filing of 2023 Universal Registration Document and US Form 20-F
Saint-Herblain (France), March 25, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, announced today the filing, on March 22, 2024, of its 2023 Universal Registration Document (URD) with the French Financial Markets Authority (AMF) under the filing number D.24-0157 and its Form 20-F with the U.S. Securities and Exchange Commission (SEC). Valneva’s 2023 Universal Registration Document – available in its entirety in French – includes the Company’s 2023 Annual Fina
